InfuSystem Holdings (INFU) Cash & Equivalents (2010 - 2026)
InfuSystem Holdings' (INFU) quarterly Cash & Equivalents came in at $2.1 million in Q1 2026, up 39.84% YoY from $1.5 million in Q1 2025, and down 33.9% on a QoQ basis from $3.2 million in Q4 2025.
InfuSystem Holdings (INFU) Cash & Equivalents (2010 - 2026) Analysis & Trends
InfuSystem Holdings (INFU) has 17 years of Cash & Equivalents data on file, last reported at $2.1 million in Q1 2026.
- Quarterly Cash & Equivalents rose 39.84% year-over-year to $2.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.1 million (up 39.84% YoY) and the FY2025 annual result came in at $3.2 million, up 504.55% from the prior year.
- Cash & Equivalents retreated to $2.1 million in Q1 2026, from $3.2 million in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $3.2 million in Q4 2025 to a low of $134000.0 in Q2 2023.
- A 5-year average of $727882.4 and a median of $380000.0 in 2024 frame the typical range for Cash & Equivalents.
- Annual changes were most pronounced in 2022 — Cash & Equivalents plunged 85.33% — and 2025, when it surged 504.55%.
- Tracing INFU's Cash & Equivalents over 5 years: stood at $165000.0 in 2022, then jumped by 40.0% to $231000.0 in 2023, then soared by 128.14% to $527000.0 in 2024, then surged by 504.55% to $3.2 million in 2025, then sank by 33.9% to $2.1 million in 2026.
- The last three Cash & Equivalents figures came in at $2.1 million (Q1 2026), $3.2 million (Q4 2025), and $955000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | 5.10 Bn |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | 3.39 Bn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 1.95 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | 2.91 Bn |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | 1.11 Bn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | 3.25 Bn |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 482.30 Mn |
| 10 | InfuSystem Holdings | 244.47 Mn | 243.50 Mn | 21.41 Mn | 964,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 964,000.00 |
| Mar 31, 2026 | 2.11 Mn |
| Dec 31, 2025 | 3.19 Mn |
| Sep 30, 2025 | 955,000.00 |
| Jun 30, 2025 | 720,000.00 |
| Mar 31, 2025 | 1.51 Mn |
| Dec 31, 2024 | 527,000.00 |
| Sep 30, 2024 | 380,000.00 |
| Jun 30, 2024 | 146,000.00 |
| Mar 31, 2024 | 822,000.00 |
| Dec 31, 2023 | 231,000.00 |
| Sep 30, 2023 | 161,000.00 |
| Jun 30, 2023 | 134,000.00 |
| Mar 31, 2023 | 256,000.00 |
| Dec 31, 2022 | 165,000.00 |
| Sep 30, 2022 | 363,000.00 |
| Jun 30, 2022 | 311,000.00 |
| Mar 31, 2022 | 405,000.00 |
| Dec 31, 2021 | 186,000.00 |
| Sep 30, 2021 | 165,000.00 |